{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:42:26Z","timestamp":1787164946179,"version":"build-2736575974"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260255-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The risk of cognitive decline and dementia following cardiovascular disease (CVD) events is well recognized. However, it remains unclear whether cognitive changes observed after such events reflect a process that begins prior to the event itself.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260255-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the cognitive trajectories of older adults preceding an incident CVD event with those of a matched control group without an event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260255-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Data for this nested case-control study were obtained from a prospective cohort of older, community-dwelling individuals (aged \u226565 years) in Australia and the US with no history of CVD at the time of study enrollment in the Aspirin in Reducing Events in the Elderly (ASPREE) randomized clinical trial and the extension (ASPREE-XT) observational study. The ASPREE trial was conducted between March 2010 and December 2014, with follow-up to June 2017. The ongoing ASPREE-XT trial continued annual follow-up; this study reports data through December 2022. Case patients with an adjudicated CVD event, including fatal coronary heart disease (CHD), nonfatal myocardial infarction (MI), fatal or nonfatal stroke, and hospitalization for heart failure (HHF), were matched by age, sex, and educational attainment to control participants without a CVD event. Data were analyzed from June to December 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260255-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Cognitive function as assessed by the Modified Mini-Mental State Examination, the Hopkins Verbal Learning Test\u2013Revised, the Symbol Digit Modalities Test, and the Controlled Oral Word Association Test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260255-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Linear mixed-effects models were used to estimate the trajectories of cognitive function among case patients with a CVD event and control participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260255-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over 11 years, 1934 CVD events occurred among 19\u202f114 participants. In this analysis, 1887 of 1934 case patients (97.6%) with adjudicated CVD events were matched to 7548 control participants (N\u2009=\u20099435; overall median age, 75.7 years [IQR, 72.4-80.0 years]; 4970 males [52.7%]). Individuals with incident CVD events had lower cognitive function, starting at between 3 and 8 years before the event, compared with those without CVD. Faster declines in global cognition (\u03b2, \u22120.19 [95% CI, \u22120.33 to \u22120.06]), episodic memory (\u03b2, \u22120.04 [\u22120.11 to \u22120.03]), processing speed (\u03b2, \u22120.28 [95% CI, \u22120.48 to \u22120.07]), and verbal fluency (\u03b2, \u22120.15 [95% CI, \u22120.27 to \u22120.04]) in the years prior to the CVD event were also observed compared with control participants. Composite global cognition (\u03b2, \u22120.11 [95% CI, \u22120.17 to \u22120.06]) and executive function scores (\u03b2, \u22120.07 [95% CI, \u22120.11 to \u22120.03]), but not memory, also declined faster. Similar cognitive trajectories were observed for fatal CHD, stroke, and HHF; however, this pattern was not observed for nonfatal MI, in which case patients and control participants showed comparable trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260255-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this case-control study of community-dwelling older adults, deterioration in cognitive function was prominent prior to CVD events, suggesting that this decline may be associated with subsequent CVD events. These findings may help inform future research aimed at understanding the association between cognitive change and CVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.7841","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:30:39Z","timestamp":1776699039000},"page":"e267841","source":"Crossref","is-referenced-by-count":1,"title":["Cognitive Decline Preceding Incident Cardiovascular Events in Older Adults"],"prefix":"10.1001","volume":"9","author":[{"given":"Swarna","family":"Vishwanath","sequence":"first","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tonkin","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C.","family":"Cloud","sequence":"additional","affiliation":[{"name":"School of Translational Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Department of Neurology, Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hopper","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"General Medicine Unit, Department of Cardiology, Alfred Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G.","family":"Orchard","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Wolfe","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj C.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Family and Preventive Medicine, Rush Alzheimer\u2019s Disease Center, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Murray","sequence":"additional","affiliation":[{"name":"Berman Center for Outcomes and Clinical Research, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"},{"name":"Division of Geriatrics, Department of Medicine, Hennepin Healthcare, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Woods","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Nelson","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Stocks","sequence":"additional","affiliation":[{"name":"Discipline of General Practice, Adelaide University, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"},{"name":"School of Population Health, Curtin University, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Venkataraman","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P.","family":"Abhayaratna","sequence":"additional","affiliation":[{"name":"School of Medicine and Psychology, The Australian National University, Canberra, Australian Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Donnan","sequence":"additional","affiliation":[{"name":"Melbourne Brain Centre, University of Melbourne, Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Eaton","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Brown University Warren Alpert Medical School, Pawtucket, Rhode Island"},{"name":"Department of Epidemiology, Brown University School of Public Health, Pawtucket, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff D.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Section on Geriatric Medicine, Sticht Center for Healthy Aging and Alzheimer\u2019s Prevention, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Ernst","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, Iowa City"},{"name":"Department of Family and Community Medicine, Carver College of Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"zoi260255r1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fpubh.2017.00335","article-title":"Age-related diseases and clinical and public health implications for the 85 years old and over population.","volume":"5","author":"Jaul","year":"2017","journal-title":"Front Public Health"},{"issue":"8","key":"zoi260255r2","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/STROKEAHA.123.040499","article-title":"Cognitive impairment in patients with cardiac disease: implications for clinical practice.","volume":"54","author":"van Nieuwkerk","year":"2023","journal-title":"Stroke"},{"issue":"2","key":"zoi260255r3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ejhf.631","article-title":"Heart failure and risk of dementia: a Danish nationwide population-based cohort study.","volume":"19","author":"Adelborg","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"zoi260255r4","doi-asserted-by":"publisher","DOI":"10.3389\/fepid.2023.1095236","article-title":"Cardiovascular disease, associated risk factors, and risk of dementia: an umbrella review of meta-analyses.","volume":"3","author":"Brain","year":"2023","journal-title":"Front Epidemiol"},{"issue":"3","key":"zoi260255r5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3233\/JAD-215644","article-title":"Post-stroke cognitive impairment: epidemiology, risk factors, and management.","volume":"86","author":"Huang","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"zoi260255r6","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jalz.2018.06.3061","article-title":"Stroke and dementia risk: a systematic review and meta-analysis.","volume":"14","author":"Kuzma","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"5","key":"zoi260255r7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018492","article-title":"Associations between heart failure and risk of dementia: a PRISMA-compliant meta-analysis.","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"zoi260255r8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jacasi.2022.09.016","article-title":"Incidence, clinical correlates, and prognostic impact of dementia in heart failure: a population-based cohort study.","volume":"3","author":"Ren","year":"2023","journal-title":"JACC Asia"},{"issue":"1","key":"zoi260255r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11065-017-9359-z","article-title":"The effect of non-stroke cardiovascular disease states on risk for cognitive decline and dementia: a systematic and meta-analytic review.","volume":"28","author":"Stefanidis","year":"2018","journal-title":"Neuropsychol Rev"},{"issue":"6","key":"zoi260255r10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/CIRCULATIONAHA.117.029127","article-title":"Higher risk of vascular dementia in myocardial infarction survivors.","volume":"137","author":"Sundb\u00f8ll","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"zoi260255r11","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jalz.2018.01.007","article-title":"Coronary heart disease, heart failure, and the risk of dementia: a systematic review and meta-analysis.","volume":"14","author":"Wolters","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"2","key":"zoi260255r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004343","article-title":"Health outcomes after myocardial infarction: a population study of 56 million people in England.","volume":"21","author":"Hall","year":"2024","journal-title":"PLoS Med"},{"issue":"1","key":"zoi260255r13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jama.2015.6968","article-title":"Trajectory of cognitive decline after incident stroke.","volume":"314","author":"Levine","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"zoi260255r14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000319564","article-title":"Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease.","volume":"30","author":"Okonkwo","year":"2010","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"zoi260255r15","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1093\/eurheartj\/ehx365","article-title":"Cognitive changes in prevalent and incident cardiovascular disease: a 12-year follow-up in the Maastricht Aging Study (MAAS).","volume":"43","author":"Schievink","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"zoi260255r16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13195-024-01479-8","article-title":"The impact of incident stroke on cognitive trajectories in later life.","volume":"16","author":"Vishwanath","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"zoi260255r17","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/alz.13006","article-title":"Cognitive trajectories and incident dementia after a cardiovascular event in older adults.","volume":"19","author":"Vishwanath","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"10","key":"zoi260255r18","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1212\/01.WNL.0000161850.01792.77","article-title":"Cognitive function predicts first-time stroke and heart disease.","volume":"64","author":"Elkins","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"zoi260255r19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/gerona\/glx138","article-title":"Cognitive function and changes in cognitive function as predictors of incident cardiovascular disease: the Women\u2019s Health Initiative Memory Study.","volume":"73","author":"Leng","year":"2017","journal-title":"Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi260255r20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1186\/s12889-021-10843-4","article-title":"Lowered cognitive function and the risk of the first events of cardiovascular diseases: findings from a cohort study in Lithuania.","volume":"21","author":"Luksiene","year":"2021","journal-title":"BMC Public Health"},{"issue":"2","key":"zoi260255r21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/HJH.0000000000000025","article-title":"Association of cognitive dysfunction with cardiovascular disease events in elderly hypertensive patients.","volume":"32","author":"Yano","year":"2014","journal-title":"J Hypertens"},{"issue":"11","key":"zoi260255r22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jnnp-2021-326043","article-title":"Long-term trajectories of decline in cognition and daily functioning before and after stroke.","volume":"92","author":"Heshmatollah","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"zoi260255r23","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.jacc.2019.04.019","article-title":"Cognitive decline before and after incident coronary events.","volume":"73","author":"Xie","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi260255r24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cct.2013.09.014","article-title":"Study design of Aspirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.","volume":"36","author":"Group","year":"2013","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"zoi260255r25","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/gerona\/glw342","article-title":"Baseline characteristics of participants in the ASPREE (Aspirin in Reducing Events in the Elderly) study.","volume":"72","author":"McNeil","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"zoi260255r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107231","article-title":"Health characteristics and aspirin use in participants at the baseline of the Aspirin in Reducing Events in the Elderly\u2013Extension (ASPREE-XT) observational study.","volume":"130","author":"Ernst","year":"2023","journal-title":"Contemp Clin Trials"},{"issue":"16","key":"zoi260255r27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi260255r28","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1212\/WNL.0000000000009277","article-title":"Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.","volume":"95","author":"Ryan","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"zoi260255r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.58591","article-title":"Cardiometabolic trajectories preceding dementia in community-dwelling older individuals.","volume":"8","author":"Wu","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260255r30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12874-020-01007-w","article-title":"Application of the matched nested case-control design to the secondary analysis of trial data.","volume":"20","author":"Partlett","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"13","key":"zoi260255r32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest package: tests in linear mixed effects models.","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J Stat Softw"},{"issue":"2","key":"zoi260255r34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1037\/0882-7974.12.2.277","article-title":"Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults.","volume":"12","author":"Lewinsohn","year":"1997","journal-title":"Psychol Aging"},{"issue":"3","key":"zoi260255r35","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype.","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi260255r36","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1212\/WNL.0000000000007716","article-title":"Progression of cognitive decline before and after incident stroke.","volume":"93","author":"Zheng","year":"2019","journal-title":"Neurology"},{"key":"zoi260255r37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.889543","article-title":"Cognition impairment and risk of subclinical cardiovascular disease in older adults: the Atherosclerosis Risk in Communities study.","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"zoi260255r38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1474-4422(05)70286-6","article-title":"A life-course approach to the aetiology of late-onset dementias.","volume":"5","author":"Whalley","year":"2006","journal-title":"Lancet Neurol"},{"issue":"20","key":"zoi260255r39","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.119.040631","article-title":"Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury.","volume":"140","author":"DeFilippis","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"zoi260255r40","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jamainternmed.2021.5726","article-title":"Assessment of nonfatal myocardial infarction as a surrogate for all-cause and cardiovascular mortality in treatment or prevention of coronary artery disease: a meta-analysis of randomized clinical trials.","volume":"181","author":"O\u2019Fee","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi260255r41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/STROKEAHA.119.026170","article-title":"Global burden of small vessel disease\u2013related brain changes on MRI predicts cognitive and functional decline.","volume":"51","author":"Jokinen","year":"2020","journal-title":"Stroke"},{"issue":"7","key":"zoi260255r42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"zoi260255r43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrcardio.2014.223","article-title":"A major role for cardiovascular burden in age-related cognitive decline.","volume":"12","author":"Qiu","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"zoi260255r44","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1097\/MS9.0000000000001441","article-title":"Stroke and cognitive impairment: understanding the connection and managing symptoms.","volume":"85","author":"Elendu","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"zoi260255r46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1037\/neu0000324","article-title":"Cognitive processing speed mediates the effects of cardiovascular disease on executive functioning.","volume":"31","author":"Liebel","year":"2017","journal-title":"Neuropsychology"},{"issue":"4","key":"zoi260255r47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.trci.2017.09.002","article-title":"Speed of processing training results in lower risk of dementia.","volume":"3","author":"Edwards","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"issue":"5","key":"zoi260255r48","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","article-title":"Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis.","volume":"23","author":"Benedict","year":"2017","journal-title":"Mult Scler"},{"issue":"8","key":"zoi260255r49","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/JGP.0b013e3181cdecf1","article-title":"Neuropsychological predictors of transition from healthy cognitive aging to mild cognitive impairment: the PATH Through Life study.","volume":"18","author":"Cherbuin","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"zoi260255r50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnagi.2017.00062","article-title":"Cognitive processing speed across the lifespan: beyond the influence of motor speed.","volume":"9","author":"Ebaid","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"zoi260255r51","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2025.100395","article-title":"A single center study of the Symbol Digit Modalities test as a screening tool for cognitive impairment in Parkinson\u2019s disease.","volume":"13","author":"Thomason","year":"2025","journal-title":"Clin Park Relat Disord"},{"issue":"1","key":"zoi260255r52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/ADR-200194","article-title":"Normative data for the Symbol Digit Modalities Test in older White Australians and Americans, African-Americans, and Hispanic\/Latinos.","volume":"4","author":"Ryan","year":"2020","journal-title":"J Alzheimers Dis Rep"},{"issue":"1","key":"zoi260255r53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/arclin\/acab029","article-title":"Performances on the Montreal Cognitive Assessment along the cardiovascular disease continuum.","volume":"37","author":"Gagnon","year":"2022","journal-title":"Arch Clin Neuropsychol"},{"key":"zoi260255r31","volume-title":"Stata Statistical Software: Release 17","author":"StataCorp","year":"2021"},{"key":"zoi260255r45","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1007\/978-3-030-22009-9_722","volume-title":"Encyclopedia of Gerontology and Population Aging","author":"Kraft","year":"2021"},{"key":"zoi260255r33","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2024. Accessed September 15, 2024. https:\/\/www.R-project.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2847956\/vishwanath_2026_oi_260255_1776101090.54055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:30:42Z","timestamp":1776699042000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.7841","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]}}}